Grupo Gallego de Investigación en Oncología de Precisión
ONCOGAL
![Foto de Grupo Gallego de Investigación en Oncología de Precisión](/img/grupo.png)
![Foto de Institut d'Investigació Biomédica de Bellvitge](/img/noimage_org.png)
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (8)
2022
-
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
Clinical Epigenetics, Vol. 14, Núm. 1
2021
-
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
npj Precision Oncology, Vol. 5, Núm. 1
2017
-
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563
-
Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers
Modern Pathology, Vol. 30, Núm. 1, pp. 134-145
-
Obesity and menopause modify the epigenomic profile of breast cancer
Endocrine-related cancer, Vol. 24, Núm. 7, pp. 351-363
2016
-
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
The Lancet Oncology, Vol. 17, Núm. 10, pp. 1386-1395
2015
-
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer
International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873
2013
-
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial
Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453